Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurogenic differentiation factor 2 (NEUROD2) is a basic helix-loop-helix (bHLH) transcription factor critically involved in the determination and maintenance of neuronal identity during development[1][6]. NEUROD2 mediates transcriptional activation from neuron-specific promoters and regulates gene networks essential for neuronal fate specification, cortical neuron migration, dendrite and synapse development, and synaptic plasticity[4][8]. It acts as a repressor of neuronal differentiation by inducing downstream targets such as ZEB1 and controlling the repression of REST expression[6]. NEUROD2 is essential for post-migratory neuronal maturation, the establishment of proper synaptic connections, and the development of several key brain regions, including the hippocampus, cortex, amygdala, and hypothalamic-pituitary axis[6][8]. Pathogenic variants of NEUROD2 are associated with early-onset epilepsy and neurodevelopmental syndromes characterized by migration defects, abnormal spine density, and impaired neuronal function[4][6]. There are currently no clinically approved drugs known to directly target NEUROD2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurogenic differentiation factor 2 (NEUROD2).